Be Biopharma Funding: $52M Raised, Series A (2020)
Be Biopharma is a Biotech company based in Cambridge, Massachusetts. It has raised $52M in total funding. Latest round: Series A.
Be Biopharma funding overview
Be Biopharma is a Biotech company based in Cambridge, Massachusetts. Be Biopharma has raised $52M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in October 2020. The round record for Be Biopharma runs through 2020; nothing later has been disclosed. Investors on record include Atlas Venture, RA Capital Management, Alta Partners, Longwood Fund, Takeda Ventures. 5 distinct backers are named across the disclosed rounds.
Be Biopharma at a glance
Total raised
$52M
Latest round
Series A
Latest round date
October 2020
Industry
Biotech
Headquarters
Cambridge, Massachusetts
Notable investors
Atlas Venture, RA Capital Management, Alta Partners, Longwood Fund, Takeda Ventures
Frequently asked about Be Biopharma funding
How much has Be Biopharma raised?
Be Biopharma has raised $52M in total disclosed funding across the rounds on record.
Who has invested in Be Biopharma?
Atlas Venture, RA Capital Management, Alta Partners, Longwood Fund, Takeda Ventures are named among the investors backing Be Biopharma.
What was the latest Be Biopharma funding round?
The most recent disclosed round is a Series A, announced in October 2020.
Where is Be Biopharma based?
Be Biopharma is based in Cambridge, Massachusetts.
What sector does Be Biopharma operate in?
Be Biopharma is tracked under Biotech from Cambridge, Massachusetts, with $52M in disclosed funding.
When did Be Biopharma last raise?
The last disclosed Be Biopharma round closed in October 2020 at Series A.
Totals shown for Be Biopharma aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Cambridge and the investors behind them below.
